Sallustio BC[au] - Search Results

Year	Number of Results
1983	1
1984	2
1985	1
1986	3
1987	1
1988	2
1989	1
1990	1
1991	3
1992	4
1993	1
1994	1
1995	2
1996	1
1997	5
1998	2
1999	3
2000	3
2001	1
2002	1
2003	1
2004	5
2005	3
2006	6
2007	5
2008	2
2010	2
2011	3
2013	3
2014	3
2015	3
2018	3
2019	4
2020	2
2021	4
2022	1

1

Is there scope for better individualisation of anthracycline cancer chemotherapy?

Sallustio BC, Boddy AV. Sallustio BC, et al. Br J Clin Pharmacol. 2021 Feb;87(2):295-305. doi: 10.1111/bcp.14628. Epub 2020 Nov 30. Br J Clin Pharmacol. 2021. PMID: 33118175 Free article. Review.

2

LC-MS/MS for immunosuppressant therapeutic drug monitoring.

Sallustio BC. Sallustio BC. Bioanalysis. 2010 Jun;2(6):1141-53. doi: 10.4155/bio.10.58. Bioanalysis. 2010. PMID: 21083213 Review.

3

Monitoring Intra-cellular Tacrolimus Concentrations in Solid Organ Transplantation: Use of Peripheral Blood Mononuclear Cells and Graft Biopsy Tissue.

Sallustio BC. Sallustio BC. Front Pharmacol. 2021 Oct 26;12:733285. doi: 10.3389/fphar.2021.733285. eCollection 2021. Front Pharmacol. 2021. PMID: 34764868 Free PMC article. Review.

4

Randomized controlled trial of perhexiline on regression of left ventricular hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM trial).

Ananthakrishna R, Lee SL, Foote J, Sallustio BC, Binda G, Mangoni AA, Woodman R, Semsarian C, Horowitz JD, Selvanayagam JB. Ananthakrishna R, et al. Among authors: sallustio bc. Am Heart J. 2021 Oct;240:101-113. doi: 10.1016/j.ahj.2021.06.010. Epub 2021 Jun 25. Am Heart J. 2021. PMID: 34175315 Clinical Trial.

5

Hepatic disposition of electrophilic acyl glucuronide conjugates.

Sallustio BC, Sabordo L, Evans AM, Nation RL. Sallustio BC, et al. Curr Drug Metab. 2000 Sep;1(2):163-80. doi: 10.2174/1389200003339153. Curr Drug Metab. 2000. PMID: 11465081 Review.

6

Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients.

Sallustio BC, Noll BD, Hu R, Barratt DT, Tuke J, Coller JK, Russ GR, Somogyi AA. Sallustio BC, et al. Br J Clin Pharmacol. 2021 Oct;87(10):3901-3909. doi: 10.1111/bcp.14806. Epub 2021 Mar 19. Br J Clin Pharmacol. 2021. PMID: 33646566

7

Some international approaches to aminoglycoside monitoring in the extended dosing interval era.

Morris RG, Sallustio BC, Vinks AA, LeGatt DF, Verjee ZH, El Desoky E. Morris RG, et al. Among authors: sallustio bc. Ther Drug Monit. 1999 Aug;21(4):379-88. doi: 10.1097/00007691-199908000-00001. Ther Drug Monit. 1999. PMID: 10442690 Review.

8

No Major Effect of Innate Immune Genetics on Acute Kidney Rejection in the First 2 Weeks Post-Transplantation.

Hu R, Barratt DT, Coller JK, Sallustio BC, Somogyi AA. Hu R, et al. Among authors: sallustio bc. Front Pharmacol. 2020 Feb 20;10:1686. doi: 10.3389/fphar.2019.01686. eCollection 2019. Front Pharmacol. 2020. PMID: 32153387 Free PMC article.

9

Relationship between allograft cyclosporin concentrations and P-glycoprotein expression in the 1st month following renal transplantation.

Sallustio BC, Noll BD, Coller JK, Tuke J, Russ G, Somogyi AA. Sallustio BC, et al. Br J Clin Pharmacol. 2019 May;85(5):1015-1020. doi: 10.1111/bcp.13880. Epub 2019 Mar 6. Br J Clin Pharmacol. 2019. PMID: 30690767 Free PMC article.

10

Stereoselective handling of perhexiline: implications regarding accumulation within the human myocardium.

Chong CR, Drury NE, Licari G, Frenneaux MP, Horowitz JD, Pagano D, Sallustio BC. Chong CR, et al. Among authors: sallustio bc. Eur J Clin Pharmacol. 2015 Dec;71(12):1485-91. doi: 10.1007/s00228-015-1934-8. Epub 2015 Sep 16. Eur J Clin Pharmacol. 2015. PMID: 26376650 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results